Email addresses
Oleme kvaliteetne hambaravi pakkuv hambakliinik Tallinnas. Pakume teenuseid nagu hambaravi, igemehaiguste ravi ja palju muud. Tule broneeri visiit!
Name
OÜ Rotermanni Hambakliinik
Registry code
12494993
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
26.06.2013 (11)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
86231 - Provision of dental treatment
-
-
-
-
-
-
Not submitted
88 590 €
-
-
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
OÜ Ivanov Holding 12886090 | 2% - 50.00 EUR | - | - | |
Kristo Ivanov 15.02.1984 (40) | 98% - 2 450.00 EUR | Board member | Direct ownership | Founder |
Pille Soom 06.06.1983 (41) | - | - | Direct ownership | Founder |
Andreas Tiik 01.08.1988 (36) | - | - | - | Founder |
2019 01.12.2020 | 2020 23.07.2021 | 2021 07.03.2023 | 2022 28.06.2023 | |
---|---|---|---|---|
Total Revenue | 1 424 761 € | 1 003 817 € | 184 950 € | 0 € |
Net profit (loss) for the period | 67 789 € | 7 861 € | -22 185 € | -559 € |
Profit Margin | 5% | 1% | -12% | - |
Current Assets | 404 440 € | 491 632 € | 365 417 € | 365 417 € |
Fixed Assets | 206 874 € | 188 157 € | 0 € | 0 € |
Total Assets | 611 314 € | 679 789 € | 365 417 € | 365 417 € |
Current Liabilities | 439 865 € | 500 479 € | 206 782 € | 172 341 € |
Non Current Liabilities | 0 € | 0 € | 0 € | 35 000 € |
Total Liabilities | - | - | - | 207 341 € |
Share Capital | - | - | - | - |
Equity | 171 449 € | 179 310 € | 158 635 € | 158 076 € |
Employees | 19 | 13 | 4 | 0 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | - | 7 999.84 € | 7 999.84 € | - |
2023 Q4 | - | 18 172.99 € | 19 999.52 € | - |
2023 Q2 | - | 2 999.68 € | 2 999.68 € | - |
2023 Q1 | - | 7 176.23 € | 7 499.68 € | 2 |
2022 Q4 | - | 9 999.68 € | 9 999.68 € | 2 |
2022 Q3 | - | 9 008.35 € | 12 999.68 € | 2 |
2022 Q2 | - | 5 999.68 € | 5 999.68 € | 2 |
2022 Q1 | - | 10 998.92 € | 11 442.34 € | 2 |
2021 Q4 | - | 6 921.5 € | 6 921.5 € | 2 |
2021 Q3 | - | 5 966.12 € | 5 966.12 € | 2 |
2021 Q2 | - | 21 959.06 € | 24 704.86 € | 2 |
2021 Q1 | - | 69 630.96 € | 75 700.15 € | 13 |
2020 Q4 | - | 10 362.21 € | 10 362.21 € | 15 |
2020 Q3 | - | 46 457.02 € | 49 435.87 € | 15 |
2020 Q2 | - | 9 584.51 € | 11 406.14 € | 16 |
2020 Q1 | - | 40 703.75 € | 43 564.24 € | 16 |